Perspective Therapeutics Inc (CATX)
3.00
-3.17
(-51.38%)
USD |
NYAM |
Nov 21, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
Perspective Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 1.717M |
| June 30, 2022 | 2.505M |
| March 31, 2022 | 2.91M |
| December 31, 2021 | 2.816M |
| September 30, 2021 | 2.564M |
| June 30, 2021 | 2.71M |
| March 31, 2021 | 2.60M |
| December 31, 2020 | 2.359M |
| September 30, 2020 | 2.384M |
| June 30, 2020 | 2.279M |
| March 31, 2020 | 2.88M |
| December 31, 2019 | 2.206M |
| September 30, 2019 | 2.315M |
| June 30, 2019 | 1.924M |
| March 31, 2019 | 1.924M |
| December 31, 2018 | 1.904M |
| September 30, 2018 | 1.562M |
| June 30, 2018 | 1.603M |
| March 31, 2018 | 1.573M |
| December 31, 2017 | 1.536M |
| September 30, 2017 | 1.211M |
| June 30, 2017 | 1.37M |
| March 31, 2017 | 1.282M |
| December 31, 2016 | 1.028M |
| September 30, 2016 | 1.081M |
| Date | Value |
|---|---|
| June 30, 2016 | 1.12M |
| March 31, 2016 | 1.199M |
| December 31, 2015 | 1.189M |
| September 30, 2015 | 1.261M |
| June 30, 2015 | 1.340M |
| March 31, 2015 | 1.158M |
| December 31, 2014 | 1.066M |
| September 30, 2014 | 1.042M |
| June 30, 2014 | 0.9495M |
| March 31, 2014 | 1.134M |
| December 31, 2013 | 1.085M |
| September 30, 2013 | 1.050M |
| June 30, 2013 | 1.242M |
| March 31, 2013 | 1.252M |
| December 31, 2012 | 0.9755M |
| September 30, 2012 | 1.056M |
| June 30, 2012 | 1.312M |
| March 31, 2012 | 1.317M |
| December 31, 2011 | 1.229M |
| September 30, 2011 | 1.213M |
| June 30, 2011 | 1.256M |
| March 31, 2011 | 1.411M |
| December 31, 2010 | 1.245M |
| September 30, 2010 | 1.327M |
| June 30, 2010 | 1.335M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.717M
Minimum
Sep 2022
2.91M
Maximum
Mar 2022
2.494M
Average
2.534M
Median
Revenue (Quarterly) Benchmarks
| Plus Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| InfuSystems Holdings Inc | 35.32M |
| Xtant Medical Holdings Inc | 27.94M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.12M |
| Total Expenses (Quarterly) | 18.63M |
| EPS Diluted (Quarterly) | -0.21 |
| Enterprise Value | -63.40M |
| Earnings Yield | -48.67% |
| Normalized Earnings Yield | -20.00 |